Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
There’s no Stopping Gilead Sciences
There’s no Stopping Gilead Sciences
Motley Fool
Gilead
India's Piramal Healthcare to borrow for future buys
India's Piramal Healthcare to borrow for future buys
Reuters
Piramal Healthcare
M&A
India
Merck to file application this year for insomnia drug
Merck to file application this year for insomnia drug
Reuters
insomnia
Merck
suvorexant
Small Pharma With Big Compounds: Final Dance With The FDA
Small Pharma With Big Compounds: Final Dance With The FDA
Seeking Alpha
GSK
AstraZeneca
FDA
Eli Lilly
Pfizer
Vivus
Merck
MAP Pharmaceuticals
Compugen Jumps to 6-Year High in Tel Aviv on Cancer Treatment Technology
Compugen Jumps to 6-Year High in Tel Aviv on Cancer Treatment Technology
Bloomberg
CompuGen
They Just Don't Get Merck!
They Just Don't Get Merck!
The Street
Merck
AstraZeneca's Shrinking Act Could Increase Its Appeal
AstraZeneca's Shrinking Act Could Increase Its Appeal
Seeking Alpha
AstraZeneca
2 Life Sciences IPOs Debut Below Target
2 Life Sciences IPOs Debut Below Target
Seeking Alpha
Greenway Medical Technologies
Cempra
Lupin Limited: Buy
Lupin Limited: Buy
Hindu Business Line, India
Lupin
New rules could save billions in prescription drug costs
New rules could save billions in prescription drug costs
Boston Herald, MA
Medicaid
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »